Literature DB >> 8829493

Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behçet's disease.

M Calgüneri1, I Ertenli, S Kiraz, M Erman, I Celik.   

Abstract

BACKGROUND: Recent studies point out a probable role of streptococcal antigens in the pathogenesis of Behçet's disease (BD). This has led to the proposal of benzathine penicillin as a therapeutic modality in BD.
OBJECTIVE: A prospective study was conducted to compare the efficacy of colchicine and colchicine + benzathine penicillin treatments on mucocutaneous manifestations of BD.
METHODS: 60 patients (group I) were given colchicine alone and 94 (group II) were given colchicine + benzathine penicillin. Frequency, number, duration and severity of oral aphthous ulcers, genital ulcers and erythema nodosum were determined before and after treatment.
RESULTS: In group I, all parameters of oral ulcers and the frequency and healing time of genital ulcers and erythema nodosum decreased significantly. In group II, all parameters of oral aphthous ulcers, genital ulcers and erythema nodosum were significantly improved. When treatment results in the two groups were compared, the decrements in the frequency and duration of oral ulcers and erythema nodosum and the frequency of genital ulcers were significantly greater in group II than in group I (p < 0.05).
CONCLUSION: We conclude that prophylactic benzathine penicillin combined with colchicine is more effective in controlling mucocutaneous manifestations of BD than colchicine alone.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8829493     DOI: 10.1159/000246336

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  24 in total

Review 1.  Behçet's disease.

Authors:  V Kontogiannis; R J Powell
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

Review 2.  Behçet's disease: from Hippocrates to the third millennium.

Authors:  D H Verity; G R Wallace; R W Vaughan; M R Stanford
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

3.  The anti-Helicobacter pylori antibiotherapy for the treatment of recurrent oral aphthous ulcers in a patient with Behcet's syndrome.

Authors:  Beytullah Yildirim; Mehmet Akif Oztürk; Selahattin Unal
Journal:  Rheumatol Int       Date:  2008-09-20       Impact factor: 2.631

Review 4.  Update on the therapy of Behçet disease.

Authors:  Zeinab Saleh; Thurayya Arayssi
Journal:  Ther Adv Chronic Dis       Date:  2014-05       Impact factor: 5.091

Review 5.  Interventions for the management of oral ulcers in Behçet's disease.

Authors:  Jennifer Taylor; Anne-Marie Glenny; Tanya Walsh; Paul Brocklehurst; Philip Riley; Rachel Gorodkin; Michael N Pemberton
Journal:  Cochrane Database Syst Rev       Date:  2014-09-25

Review 6.  Immunopathogenesis of Behçet's disease with special emphasize on the possible role of antigen presenting cells.

Authors:  Salih Pay; Ismail Simşek; Hakan Erdem; Ayhan Dinç
Journal:  Rheumatol Int       Date:  2007-03       Impact factor: 2.631

Review 7.  Pharmacotherapy for Behcet's syndrome.

Authors:  A Saenz; M Ausejo; B Shea; G Wells; V Welch; P Tugwell
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 8.  Behçet Disease: An Update for Dermatologists.

Authors:  Erkan Alpsoy; Burcin Cansu Bozca; Asli Bilgic
Journal:  Am J Clin Dermatol       Date:  2021-06-01       Impact factor: 7.403

9.  The pustular skin lesions in Behcet's syndrome are not sterile.

Authors:  G Hatemi; H Bahar; S Uysal; C Mat; F Gogus; S Masatlioglu; K Altas; H Yazici
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

10.  Managing Behçet's disease: An update on current and emerging treatment options.

Authors:  P La van Daele; J H Kappen; P M van Hagen; J Am van Laar
Journal:  Ther Clin Risk Manag       Date:  2009-05-20       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.